- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hazardous; Use, Alcohol in India
Total 84 results
-
University of PennsylvaniaAll India Institute of Medical Sciences, New DelhiCompleted
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon-alcoholic SteatohepatitisIndia
-
Medanta, The Medicity, IndiaCompletedNon Alcoholic Fatty Liver DiseaseIndia
-
Asian Institute of Gastroenterology, IndiaUnknownObesity | Diabetes Mellitus, Type 2 | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic SteatohepatitisIndia
-
Institute of Liver and Biliary Sciences, IndiaUnknownNon-Alcoholic Fatty Liver DiseaseIndia
-
Institute of Liver and Biliary Sciences, IndiaCompletedLiver CirrhosisIndia
-
Post Graduate Institute of Medical Education and...Not yet recruitingNon-Alcoholic Fatty Liver Disease | Hepatic Steato-FibrosisIndia
-
All India Institute of Medical Sciences, New DelhiPostgraduate Institute of Medical Education and Research; Jawaharlal Institute...CompletedSepsis | Septic Shock | Antimicrobial Resistance | Procalcitonin | Antibiotic Use | PCT | AMRIndia
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Institute of Liver and Biliary Sciences, IndiaRecruitingMetabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseIndia
-
Medanta, The Medicity, IndiaCompletedType2 Diabetes Mellitus | Non Alcoholic Fatty Liver DiseaseIndia
-
Asian Institute of Gastroenterology, IndiaRecruiting
-
Post Graduate Institute of Medical Education and...RecruitingFatty Liver | NAFLD | Cardiac DiseaseIndia
-
Command Hospital, IndiaUnknown
-
All India Institute of Medical Sciences, BhubaneswarRecruitingHypertension | Hypothyroidism | Sleep Apnea | Morbid Obesity | Lipid Disorder | Non-Alcoholic Fatty Liver Disease | Type2diabetes | Chronic Venous Hypertension With UlcerIndia
-
Wake Forest University Health SciencesCompletedDepression | Anxiety | Substance Use DisorderUnited States
-
Medanta, The Medicity, IndiaDiabetes & Endocrinology FoundationRecruitingType 2 Diabetes | Non Alcholic Fatty Liver DiseaseIndia
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Institute of Liver and Biliary Sciences, IndiaWithdrawn
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Belgium, Germany, Taiwan, Austria, United States, Spain, Korea, Republic of, Argentina, Australia, Italy, Japan, Singapore, Netherlands, Slovakia, France, Canada, India
-
Ali AminianNot yet recruitingObesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
Zydus Lifesciences LimitedRecruitingObesity | Metabolic Syndrome | Dyslipidemias | Type 2 Diabetes | NAFLDIndia
-
Novartis PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, South Africa, Spain, Germany, Italy, Taiwan, Canada, Korea, Republic of, Singapore, Bulgaria, Estonia, Mexico, Japan, Denmark, United Kingdom, Colombia, Brazil, Belgium, Russian Federation, Puerto Rico, Chile, Argen... and more
-
Novo Nordisk A/SActive, not recruitingNon-alcoholic SteatohepatitisSpain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
-
Novo Nordisk A/SRecruitingNon-alcoholic SteatohepatitisUnited States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more
-
GlaxoSmithKlineRecruitingNonalcoholic Fatty Liver DiseaseUnited States, Australia, Italy, Japan, Spain, Belgium, Argentina, Canada, United Kingdom, Korea, Republic of, France, Greece, India, Mexico, Puerto Rico, Turkey, Panama
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisHong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India
-
AstraZenecaAstraZeneca K.K.RecruitingNonalcoholic SteatohepatitisUnited States, China, Korea, Republic of, Germany, Japan, Spain, Vietnam, Argentina, Colombia, Peru, Brazil, Malaysia, Taiwan, Thailand, Italy, Turkey, Hong Kong, Singapore, India, Mexico, Chile, Philippines, Portugal
-
Akero Therapeutics, IncRecruitingNASH With Fibrosis | MASH With FibrosisUnited States, Canada, Puerto Rico, Australia, India, France, Italy, Poland, Spain
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
GlaxoSmithKlineTerminatedLiver Diseases | HIV Infection | Thrombocytopenia | Hepatitis C Virus | HBV | NASH - Nonalcoholic Steatohepatitis | Human Immunodeficiency Virus | Chronic Liver Disease | HCV | Non-alcoholic Steatohepatitis | Hepatitis B VirusUnited States, Spain, Taiwan, Italy, Belgium, France, Korea, Republic of, Canada, Russian Federation, Pakistan, Poland, India, Argentina